Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment - PubMed (original) (raw)
. 2012 Dec 5;696(1-3):54-61.
doi: 10.1016/j.ejphar.2012.09.006. Epub 2012 Sep 19.
Affiliations
- PMID: 23001013
- DOI: 10.1016/j.ejphar.2012.09.006
Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment
M Anitha et al. Eur J Pharmacol. 2012.
Abstract
The incidence of type 2 diabetes mellitus is rising at alarming proportions. Central nervous system plays an important part in orchestrating glucose metabolism, with accumulating evidence linking dysregulated central nervous system circuits to the failure of normal glucoregulatory mechanisms. Pyridoxine is a water soluble vitamin and it has important role in brain function. This study aims to evaluate the role of pyridoxine in striatal glucose regulation through dopaminergic receptor expressions in streptozotocin induced diabetic rats. Radio receptor binding assays for dopamine D(1), D(2) receptors were done using [(3)H] 7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol and [(3)H] 5-chloro-2-methoxy-4-methylamino-N-[-2-methyl-1-(phenylmethyl)pyrrolidin-3-yl]benzamide. Gene expressions were done using fluorescently labeled Taqman probes of dopamine D(1), D(2) receptor, Insulin receptor, Insulin like growth factor-1(IGF-1) and Glucose transporter-3 (GLUT-3). Bmax of dopamine D(1) receptor is decreased and B(max) of dopamine D(2) was increased in diabetic rats compared to control. Gene expression of dopamine D(1) receptor was down regulated and dopamine D(2) receptor was up regulated in diabetic rats. Our results showed decreased gene expression of Insulin receptor, IGF-1 and increased gene expression of GLUT-3 in diabetic rats compared to control. Pyridoxine treatment restored diabetes induced alterations in dopamine D(1), D(2) receptors, Insulin receptor, IGF-1, GLUT-3 gene expressions in striatum compared to diabetic rats. Insulin treatment reversed dopamine D(1), D(2) receptor, GLUT-3 mRNA expression, D(2) receptor binding parameters in the striatum compared to diabetic group. Our results suggest the potential role of pyridoxine supplementation in ameliorating diabetes mediated dysfunctions in striatal dopaminergic receptor expressions and insulin signaling. Thus pyridoxine has therapeutic significance in diabetes management.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
- Down regulation of cerebellar serotonergic receptors in streptozotocin induced diabetic rats: Effect of pyridoxine and Aegle marmelose.
Abraham PM, Paul J, Paulose CS. Abraham PM, et al. Brain Res Bull. 2010 Apr 29;82(1-2):87-94. doi: 10.1016/j.brainresbull.2010.02.005. Epub 2010 Feb 17. Brain Res Bull. 2010. PMID: 20170713 - Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats.
Kumar PT, Antony S, Nandhu MS, Sadanandan J, Naijil G, Paulose CS. Kumar PT, et al. J Nutr Biochem. 2011 May;22(5):418-25. doi: 10.1016/j.jnutbio.2010.03.010. Epub 2010 Jul 23. J Nutr Biochem. 2011. PMID: 20655720 - Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation.
Peeyush KT, Savitha B, Sherin A, Anju TR, Jes P, Paulose CS. Peeyush KT, et al. Pharmacol Biochem Behav. 2010 Apr;95(2):216-22. doi: 10.1016/j.pbb.2010.01.008. Epub 2010 Jan 22. Pharmacol Biochem Behav. 2010. PMID: 20096724 - Serotonergic receptor upregulation in cerebral cortex and down regulation in brainstem of streptozotocin induced diabetic rats: antagonism by pyridoxine and insulin.
Abraham PM, Anju TR, Jayanarayanan S, Paulose CS. Abraham PM, et al. Neurosci Lett. 2010 Oct 8;483(1):23-7. doi: 10.1016/j.neulet.2010.07.042. Epub 2010 Jul 22. Neurosci Lett. 2010. PMID: 20655360 - Dopaminergic drugs in type 2 diabetes and glucose homeostasis.
Lopez Vicchi F, Luque GM, Brie B, Nogueira JP, Garcia Tornadu I, Becu-Villalobos D. Lopez Vicchi F, et al. Pharmacol Res. 2016 Jul;109:74-80. doi: 10.1016/j.phrs.2015.12.029. Epub 2015 Dec 31. Pharmacol Res. 2016. PMID: 26748034 Review.
Cited by
- Sex-dependent alterations of dopamine receptor and glucose transporter density in rat hypothalamus under long-term clozapine and haloperidol medication.
Bouvier ML, Fehsel K, Schmitt A, Meisenzahl-Lechner E, Gaebel W, von Wilmsdorff M. Bouvier ML, et al. Brain Behav. 2020 Aug;10(8):e01694. doi: 10.1002/brb3.1694. Epub 2020 Jun 11. Brain Behav. 2020. PMID: 32525610 Free PMC article. - Deciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.
Kleinridders A. Kleinridders A. J Neuroendocrinol. 2016 Nov;28(11):10.1111/jne.12433. doi: 10.1111/jne.12433. J Neuroendocrinol. 2016. PMID: 27631195 Free PMC article. - Current Perspectives: Obesity and Neurodegeneration - Links and Risks.
Kueck PJ, Morris JK, Stanford JA. Kueck PJ, et al. Degener Neurol Neuromuscul Dis. 2023 Dec 31;13:111-129. doi: 10.2147/DNND.S388579. eCollection 2023. Degener Neurol Neuromuscul Dis. 2023. PMID: 38196559 Free PMC article. Review. - Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.
Sergi D, Renaud J, Simola N, Martinoli MG. Sergi D, et al. Front Aging Neurosci. 2019 Nov 8;11:302. doi: 10.3389/fnagi.2019.00302. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31787891 Free PMC article. - The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.
Shpakov AO, Derkach KV. Shpakov AO, et al. J Signal Transduct. 2013;2013:594213. doi: 10.1155/2013/594213. Epub 2013 Sep 28. J Signal Transduct. 2013. PMID: 24191197 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous